Rivastigmine and QT interval prolongation.
Inglis
F
F
D002219:Carbamates / Q000009:adverse effects*; D002800:Cholinesterase Inhibitors / Q000009:adverse effects*; D006801:Humans; D008133:Long QT Syndrome / Q000139:chemically induced*; D018696:Neuroprotective Agents / Q000009:adverse effects*; D048448:Phenylcarbamates; D000068836:Rivastigmine
D002219:Carbamates; D002800:Cholinesterase Inhibitors; D018696:Neuroprotective Agents; D048448:Phenylcarbamates; D000068836:Rivastigmine